Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review
Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Innoviva Inc (Innoviva) partners with companies that advance innovative therapies for improving patient care and building long-lasting value. Its operations are primarily focused on royalty management. The company partners with GSK for the commercialization and development of respiratory products. The company's current portfolio includes respiratory assets partnered with Glaxo Group Limited (GSK) for various respiratory disorders. The company's R&D also focuses on developing innovative formulations for the treatment of respiratory disorders. It receives royalty payments on the sale of these partnered products to clients as per the terms of its agreements with GSK. Innoviva is headquartered in Brisbane, California, the US.
Innoviva Inc Key Recent Developments
Feb 03,2021: Innoviva reports fourth quarter 2020 financial results
Oct 28,2020: Innoviva reports third quarter 2020 financial results
May 21,2020: Innoviva names Pavel Raifeld as Chief Executive Officer
Apr 29,2020: Innoviva reports first quarter 2020 financial results
Feb 05,2020: Innoviva reports fourth quarter 2019 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Innoviva Inc (Innoviva) partners with companies that advance innovative therapies for improving patient care and building long-lasting value. Its operations are primarily focused on royalty management. The company partners with GSK for the commercialization and development of respiratory products. The company's current portfolio includes respiratory assets partnered with Glaxo Group Limited (GSK) for various respiratory disorders. The company's R&D also focuses on developing innovative formulations for the treatment of respiratory disorders. It receives royalty payments on the sale of these partnered products to clients as per the terms of its agreements with GSK. Innoviva is headquartered in Brisbane, California, the US.
Innoviva Inc Key Recent Developments
Feb 03,2021: Innoviva reports fourth quarter 2020 financial results
Oct 28,2020: Innoviva reports third quarter 2020 financial results
May 21,2020: Innoviva names Pavel Raifeld as Chief Executive Officer
Apr 29,2020: Innoviva reports first quarter 2020 financial results
Feb 05,2020: Innoviva reports fourth quarter 2019 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Innoviva Inc - Key Facts
Innoviva Inc - Key Employees
Innoviva Inc - Key Employee Biographies
Innoviva Inc - Major Products and Services
Innoviva Inc - History
Innoviva Inc - Company Statement
Innoviva Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Innoviva Inc - Business Description
Innoviva Inc - Corporate Strategy
Innoviva Inc - SWOT Analysis
SWOT Analysis - Overview
Innoviva Inc - Strengths
Innoviva Inc - Weaknesses
Innoviva Inc - Opportunities
Innoviva Inc - Threats
Innoviva Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Innoviva Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Feb 03, 2021: Innoviva reports fourth quarter 2020 financial results
Oct 28, 2020: Innoviva reports third quarter 2020 financial results
May 21, 2020: Innoviva names Pavel Raifeld as Chief Executive Officer
Apr 29, 2020: Innoviva reports first quarter 2020 financial results
Feb 05, 2020: Innoviva reports fourth quarter 2019 financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Innoviva Inc - Key Facts
Innoviva Inc - Key Employees
Innoviva Inc - Key Employee Biographies
Innoviva Inc - Major Products and Services
Innoviva Inc - History
Innoviva Inc - Company Statement
Innoviva Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Innoviva Inc - Business Description
Innoviva Inc - Corporate Strategy
Innoviva Inc - SWOT Analysis
SWOT Analysis - Overview
Innoviva Inc - Strengths
Innoviva Inc - Weaknesses
Innoviva Inc - Opportunities
Innoviva Inc - Threats
Innoviva Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Innoviva Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Feb 03, 2021: Innoviva reports fourth quarter 2020 financial results
Oct 28, 2020: Innoviva reports third quarter 2020 financial results
May 21, 2020: Innoviva names Pavel Raifeld as Chief Executive Officer
Apr 29, 2020: Innoviva reports first quarter 2020 financial results
Feb 05, 2020: Innoviva reports fourth quarter 2019 financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Innoviva Inc, Key Facts
Innoviva Inc, Key Employees
Innoviva Inc, Key Employee Biographies
Innoviva Inc, Major Products and Services
Innoviva Inc, History
Innoviva Inc, Subsidiaries
Innoviva Inc, Key Competitors
Innoviva Inc, Ratios based on current share price
Innoviva Inc, Annual Ratios
Innoviva Inc, Annual Ratios (Cont...1)
Innoviva Inc, Interim Ratios
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Innoviva Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Innoviva Inc, Key Facts
Innoviva Inc, Key Employees
Innoviva Inc, Key Employee Biographies
Innoviva Inc, Major Products and Services
Innoviva Inc, History
Innoviva Inc, Subsidiaries
Innoviva Inc, Key Competitors
Innoviva Inc, Ratios based on current share price
Innoviva Inc, Annual Ratios
Innoviva Inc, Annual Ratios (Cont...1)
Innoviva Inc, Interim Ratios
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Innoviva Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Innoviva Inc, Performance Chart (2016 - 2020)
Innoviva Inc, Ratio Charts
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Innoviva Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Innoviva Inc, Performance Chart (2016 - 2020)
Innoviva Inc, Ratio Charts
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Innoviva Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021